메뉴 건너뛰기




Volumn 145, Issue 7, 2006, Pages

Thalidomide therapy for discoid lupus erythematosus

Author keywords

Dermatology; Discoid lupus eryhematosus (DLE); Thalidomide

Indexed keywords

THALIDOMIDE; IMMUNOSUPPRESSIVE AGENT;

EID: 33748439559     PISSN: 00177768     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (9)

References (17)
  • 1
    • 24144476634 scopus 로고    scopus 로고
    • Thalidomide: Dermatological indications, mechanisms of action and side effects
    • Wu JJ, Huang DB, Pang K R & al, Thalidomide: dermatological indications, mechanisms of action and side effects. Br J Dermatol, 2005; 153: 254-73.
    • (2005) Br J Dermatol , vol.153 , pp. 254-273
    • Wu, J.J.1    Huang, D.B.2    Pang, K.R.3
  • 3
    • 2142825614 scopus 로고    scopus 로고
    • Thalidomide: An old drug with new clinical applications
    • Laffitte E & Revuz J, Thalidomide: an old drug with new clinical applications. Expert Opin Drug Saf, 2004; 3: 47-56.
    • (2004) Expert Opin Drug Saf , vol.3 , pp. 47-56
    • Laffitte, E.1    Revuz, J.2
  • 4
    • 0028568310 scopus 로고
    • Guidelines for the clinical use and dispersing the thalidomide
    • Powell RJ & Gardner-Medwin JMH, Guidelines for the clinical use and dispersing the thalidomide. Postgrad Med J, 1994; 70: 901-904.
    • (1994) Postgrad Med J , vol.70 , pp. 901-904
    • Powell, R.J.1    Gardner-Medwin, J.M.H.2
  • 6
    • 0019974059 scopus 로고
    • Thalidomide in the treatment of chronic discoid lupus Erythematosus
    • Hasper MF & Klokke AH, Thalidomide in the treatment of chronic discoid lupus Erythematosus. Acta Derm Venereol, 1982; 62: 321-324.
    • (1982) Acta Derm Venereol , vol.62 , pp. 321-324
    • Hasper, M.F.1    Klokke, A.H.2
  • 7
    • 0024450422 scopus 로고
    • Treatment of discoid lupus erythematosus
    • Lo JS & Berg RE, Treatment of discoid lupus erythematosus. Int J Dermatol, 1989; 28: 497-507.
    • (1989) Int J Dermatol , vol.28 , pp. 497-507
    • Lo, J.S.1    Berg, R.E.2
  • 8
    • 0029758257 scopus 로고    scopus 로고
    • Tseng S, Pak G, Washenic K & al, Rediscovering thalidomide: a review of its mechanism of action, side effects and potential uses. J Am Acad Dermatol, 1996; 35: 969-979.
    • (1996) J Am Acad Dermatol , vol.35 , pp. 969-979
    • Tseng, S.1    Pak, G.2    Washenic, K.3
  • 9
    • 21844436051 scopus 로고
    • Long-term thalidomide use in refractory cutaneous lesions of lupus erythematosus; a 65 series o Brazilian patiens
    • Coelcho A, Souto MI, Cardoso CR & al, Long-term thalidomide use in refractory cutaneous lesions of lupus erythematosus; a 65 series o Brazilian patiens. Lupus, 1995; 14: 434-9.
    • (1995) Lupus , vol.14 , pp. 434-439
    • Coelcho, A.1    Souto, M.I.2    Cardoso, C.R.3
  • 10
    • 10644244376 scopus 로고    scopus 로고
    • Thalidomide treatment for hypertrophic cutaneous lupus erythemaosus
    • Gambini D, carrera C & Pasosni E, Thalidomide treatment for hypertrophic cutaneous lupus erythemaosus. J Dermatolog Treat, 2004; 15: 365-71.
    • (2004) J Dermatolog Treat , vol.15 , pp. 365-371
    • Gambini, D.1    Carrera, C.2    Pasosni, E.3
  • 11
    • 0020641543 scopus 로고
    • Knop J, Bonsmann G, Hopple R & al, Thalidomide in the treatment o sixty cases of chronic discoid lupus erythemtosus. Br J Dermatol, 1983; 108: 461-466.
    • (1983) Br J Dermatol , vol.108 , pp. 461-466
    • Knop, J.1    Bonsmann, G.2    Hopple, R.3
  • 12
    • 0035204387 scopus 로고    scopus 로고
    • Low dose thalidomide is an effective second-line treatment in cutaneous lupus erythemtosus
    • Thomson KF & Goodfield MJ, Low dose thalidomide is an effective second-line treatment in cutaneous lupus erythemtosus. J Dermatol Treat, 2001; 12: 145-147.
    • (2001) J Dermatol Treat , vol.12 , pp. 145-147
    • Thomson, K.F.1    Goodfield, M.J.2
  • 13
    • 14644394268 scopus 로고    scopus 로고
    • Thalidomide for he treatment of resistant cutaneous lupus: Efficacy and safety of different therapeutic regimes
    • Cuadrado MJ, Karim Y, Sanna G & al, Thalidomide for he treatment of resistant cutaneous lupus: efficacy and safety of different therapeutic regimes. Am J Med, 2005; 118: 246-50.
    • (2005) Am J Med , vol.118 , pp. 246-250
    • Cuadrado, M.J.1    Karim, Y.2    Sanna, G.3
  • 14
    • 8344253557 scopus 로고    scopus 로고
    • Update on the management of cutaneous lupus eryhematosus
    • Callen JP, Update on the management of cutaneous lupus eryhematosus. Br J Dermatol, 2004; 151: 731-6.
    • (2004) Br J Dermatol , vol.151 , pp. 731-736
    • Callen, J.P.1
  • 15
    • 0038310699 scopus 로고    scopus 로고
    • Thalidomide in cutaneous lupus eryhematosus
    • Pelle MT & Werth VP, Thalidomide in cutaneous lupus eryhematosus. Am J Clin Dermatol, 2003; 4: 379-87.
    • (2003) Am J Clin Dermatol , vol.4 , pp. 379-387
    • Pelle, M.T.1    Werth, V.P.2
  • 16
    • 0037231472 scopus 로고    scopus 로고
    • Low-dose thalidomide therapy for refractory cutaneous lesons of lupus eryhematosus
    • Housman TS, Jorizzo JL, McCarty MA & al, Low-dose thalidomide therapy for refractory cutaneous lesons of lupus eryhematosus. Arch Dermatol, 2003; 139: 50-4.
    • (2003) Arch Dermatol , vol.139 , pp. 50-54
    • Housman, T.S.1    Jorizzo, J.L.2    McCarty, M.A.3
  • 17
    • 2942729733 scopus 로고    scopus 로고
    • Thalidomide neurotoxicity: Prospective study in patients with lupus eryhematosus
    • Briani C, Zara G, Rondione R & al, Thalidomide neurotoxicity: prospective study in patients with lupus eryhematosus. Neurology, 2004; 62: 2288-90.
    • (2004) Neurology , vol.62 , pp. 2288-2290
    • Briani, C.1    Zara, G.2    Rondione, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.